Stay informed with the latest litigation news. Explore now

IP Verse

Rinat Neuroscience competitive analysis

Latest publications and patents of Rinat Neuroscience New

Explore the latest publications and patents granted to Rinat Neuroscience, showcasing their recent innovations and technological advancements.

Last updated on: Sep 6, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Rinat Neuroscience

EP2100902
Dec 18, 2019Methods For Treating Pain By Administering An Antagonist Antibody Against The Nerve Growth Factor And An Opioid Analgesic, And Compositions Containing The SameRevoked
EP2206728
Oct 10, 2018Methods For Treating Bone Cancer Pain By Administering A Nerve Growth Factor Antagonistic AntibodyRevoked
EP2305711
Aug 2, 2017Methods For Treating Osteoarthitis Pain By Administering A Nerve Growth Factor Antagonist And Compositions Containing The SameRevoked

Latest patents of Rinat Neuroscience opposed by its competitors

Explore Rinat Neuroscience's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2100902
Dec 18, 2019Methods For Treating Pain By Administering An Antagonist Antibody Against The Nerve Growth Factor And An Opioid Analgesic, And Compositions Containing The Same1
EP2206728
Oct 10, 2018Methods For Treating Bone Cancer Pain By Administering A Nerve Growth Factor Antagonistic Antibody1
EP2305711
Aug 2, 2017Methods For Treating Osteoarthitis Pain By Administering A Nerve Growth Factor Antagonist And Compositions Containing The Same2

Latest PTAB cases involving Rinat Neuroscience New

Discover the latest PTAB cases involving Rinat Neuroscience, highlighting their recent legal challenges and patent disputes.

Top competitors of Rinat Neuroscience

Top competitors of Rinat Neuroscience based on patent oppositions.